Jian‐Ming Li
Impact in
- Cancer Research top 10%
- Cancer-related molecular mechanisms research
Papers in
- Oncology 6
- Cancer Immunotherapy and Biomarkers 3
- Peptidase Inhibition and Analysis 2
- Cancer Cells and Metastasis 2
-
- Cancer-related molecular mechanisms research 2
- Co-authors
- Aijun Zhou (4 shared papers)Jian-Ping Huo (3 shared papers)Liheng Che (3 shared papers)Yunxia Zhou (2 shared papers)Rong Zhou (2 shared papers)Wen Ni (2 shared papers)Yuanyuan Zhao (3 shared papers)Tong Shen (5 shared papers)
- Journals
- Cancer Biotherapy and Radiopharmaceuticals (2 papers)Cell Metabolism (2 papers)Oncotarget (2 papers)Microbiome (1 paper)Molecular Therapy (1 paper)
- Partner nations
- ChinaHong KongUnited States
In The Last Decade
Jian‐Ming Li
22 papers receiving 771 citations
Peers
Comparison fields: 5 of 89
- Cancer Research 148
- Biological Psychiatry 24
- Oncology 177
- Immunology 139
- Endocrine and Autonomic Systems 34
Countries citing papers authored by Jian‐Ming Li
This map shows the geographic impact of Jian‐Ming Li's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jian‐Ming Li with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jian‐Ming Li more than expected).
Fields of papers citing papers by Jian‐Ming Li
This network shows the impact of papers produced by Jian‐Ming Li. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jian‐Ming Li. The network helps show where Jian‐Ming Li may publish in the future.
Co-authors
The 25 scholars most cited alongside Jian‐Ming Li, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 22 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2021 | 140 | |
| 2 | 2009 | 123 | |
| 3 | 2020 | 114 | |
| 4 | 2021 | 85 | |
| 5 | 2019 | 74 | |
| 6 | 2021 | 44 | |
| 7 | 2024 | 33 | |
| 8 | 2017 | 29 | |
| 9 | 2015 | 29 | |
| 10 | 2020 | 28 | |
| 11 | 2021 | 23 | |
| 12 | 2020 | 16 | |
| 13 | 2015 | 8 | |
| 14 | 2017 | 8 | |
| 15 | 2025 | 8 | |
| 16 | 2024 | 6 | |
| 17 | 2008 | 3 | |
| 18 | 2021 | 2 | |
| 19 | 2025 | 2 | |
| 20 | 2025 | 2 |
About Jian‐Ming Li
Jian‐Ming Li is a scholar working on Oncology, Cancer Research, Molecular Biology, Cellular and Molecular Neuroscience and Immunology, having authored 22 papers that have together received 780 indexed citations. Recurring topics across this work include Ferroptosis and cancer prognosis (3 papers), Cancer Immunotherapy and Biomarkers (3 papers), Cancer-related molecular mechanisms research (2 papers), Genital Health and Disease (2 papers), Cancer-related gene regulation (2 papers), Nuclear Receptors and Signaling (2 papers), Peptidase Inhibition and Analysis (2 papers) and Cancer Cells and Metastasis (2 papers). The work is most often cited by research in Cancer Research (148 citations), Biological Psychiatry (24 citations), Oncology (177 citations), Immunology (139 citations) and Endocrine and Autonomic Systems (34 citations). Jian‐Ming Li has collaborated with scholars based in China, Hong Kong and United States. Frequent co-authors include Aijun Zhou, Jian-Ping Huo, Liheng Che, Yunxia Zhou, Rong Zhou, Wen Ni, Yuanyuan Zhao, Tong Shen, Jingwen Liu and Tianming Gao. Their work appears in journals such as Cancer Biotherapy and Radiopharmaceuticals, Cell Metabolism, Oncotarget, Microbiome and Molecular Therapy.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.